Trade FBRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Forte Biosciences, Inc. (FBRX) is trading at US$76.99, up 0.00% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$1.63B. Over the past 52 weeks, FBRX has traded between US$10.11 and US$77.20. On Syfe you can trade FBRX with $0 commission and add it to your watchlist.
| Previous close | US$76.99 |
|---|---|
| Market cap | US$1.63B |
| 52-week range | US$10.11 – US$77.20 |
| Volume | 1.4M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Forte Biosciences, Inc.
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.
Year: 2020
Sector Update: Healthcare Stocks Advance Late Afternoon
Jul 27, 7:56 PM · MT Newswires
Top Midday Gainers
Jul 27, 5:48 PM · MT Newswires
Sector Update: Healthcare Stocks Advance Monday Afternoon
Jul 27, 5:40 PM · MT Newswires
Forte Biosciences, Inc. (FBRX) stock is trading at US$76.99, 0.00% from the previous close of US$76.99.
The market cap for Forte Biosciences, Inc. (FBRX) stock is approximately US$1.63B.
The 52-week high for Forte Biosciences, Inc. (FBRX) stock is US$77.20.
The 52-week low for Forte Biosciences, Inc. (FBRX) stock is US$10.11.
Forte Biosciences, Inc. (FBRX) does not currently pay a dividend.
Stay on top of FBRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
